Antigen Triggers in Inflammatory Skin-disease (Trial Not Registered)

ATIS

This trial is Currently recruiting
Registration number Trial Not Registered
The study aims to enrol 150 people with inflammatory skin conditions such as psoriasis. The study will collect samples from volunteers. These will be used to try and understand the role of antigen presentation in people with these diseases. Specifically, the research aims to identify pathogenic peptides in lesional vs. Non lesional skin. This could lead to more personalised and effective treatments for psoriasis and ultimately improve patient care.

Program & service

This trial is being run with the Specialty Medicine service, and as part of the Dermatology program.

Trial phase

Other

Trial participation type

This trial is for clinical research of something other than a drug or device.

Principal investigator

Prof Johannes S Kern

Key inclusion data

>18 years of age, diagnosed with psoriasis; The presence of at least one skin lesion, at least 6mm in size; No history of blood clotting disorders.

If you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.